ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
Last Updated: 14:00:11
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 11,446 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Holding(s) in Company

03/10/2008 3:33pm

UK Regulatory


    RNS Number : 0805F
  Celsis International PLC
  03 October 2008
   


 For filings with the FSA include the annex
 For filings with issuer exclude the annex 

 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying issuer   Celsis International
 of existing shares to which voting rights are        Plc
 attached:


 2. Reason for notification   (please tick the appropriate box or boxes))
                                                                                                  X
 An acquisition or disposal of voting rights

 An acquisition or disposal of financial instruments which may result in the acquisition
 of shares already issued to which voting rights are attached 

 An event changing the breakdown of voting rights

 Other (please specify):______________

 3. Full name of person(s) subject to            Barclays PLC
 notification obligation:
                                                 Barclays Global Investors Ltd
 4. Full name of shareholder(s) (if different    Barclays Life Assurance Co
 from 3):                                        Ltd
                                                 Barclays Stockbrokers Ltd

                                                 01-Oct-08
 5. Date of transaction (and date on which the
 threshold is crossed or reached if different):
                                                 02-Oct-08
 6. Date on which issuer notified:
                                                 6% to 5%
 7. Threshold(s) that is/are crossed or
 reached:


 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares  Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN  transaction
 code
                       Number of shares      Number of voting      Number of shares  Number of voting        Percentage of voting
                                             rights                                  rights                  rights

                                                                                     Direct  Indirect        Direct       Indirect
                       1,314,854             1,314,854             1,312,354         0       1,312,354       0.00         5.99
 GB00B0CD5F69



 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)




 Total (A+B)

 Number of voting rights  Percentage of voting rights
 1,312,354                5.99




 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 Barclays Global Investors Ltd
 Barclays Life Assurance Co Ltd
 Barclays Stockbrokers Ltd


 Proxy Voting:

 10. Name of proxy holder:                                         
                                                                   
 11. Number of voting rights proxy holder will cease to hold:      
                                                                   
 12. Date on which proxy holder will cease to hold voting rights:  
                                                                   

 13. Additional information:     

 14 Contact name:               Geoff Smith

 15. Contact telephone number:  020 7116 2913


    For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUOASRWURRRAA

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock